Acreage Holdings

The four MSOs that could get buzzed on Ohio

Published

1 year ago

June 4, 2024

With the Ohio adult-use cannabis sales set to launch in a matter of weeks, four multistate operators stand poised to reap significant benefits from the new market.

That’s according to equity analyst Pablo Zuanic of Zuanic & Associates, who reviewed the current landscape and the four MSOs.

Zuanic expects sales to begin July 1, just in time for the Fourth of July, which is typically a strong holiday for cannabis sales. Ohio is also expected to benefit from having very few neighbors with legal recreational markets – with Michigan the notable exception. That means it will likely draw customers from border states that have yet to see the light.

The analyst estimates that total cannabis sales – meaning both adult-use and medical – to reach $2.3 billion by the end of year. That’s based on a sales projection of $200 per capita. In the first five months of 2024, medical sales topped $205 million, according to data from the state’s Division of Cannabis Control.

Currently, the state has 123 operating medical dispensaries, plus nine with “active provisional” dispensary licenses. By mid-2025, Zuanic forecasts that the state will have 254 adult-use dispensaries.

Ohio market

According to Zuanic, 42 of the 123 operational stores (34%) are owned by public MSOs:

Acreage Holdings – 5 stores, operating under The Botanist brand
Ascend Wellness Holdings – 5 stores
The Cannabist Co. – 5 stores, four under the Columbia Care banner and one under gLeaf
Cresco Labs – 5 stores, operating as Sunnyside
Green Thumb Industries – 5 stores, under the Rise banner
Verano Holdings – 5 stores, operating as Zen Leaf
Vext Science – 4 stores (two consolidated and two under letters of intent)
Ayr Wellness – 3 stores
Curaleaf – 2 stores
Jushi Holdings – 1 store
MariMed – 1 store
Trulieve Cannabis Corp. – 1 store

In addition, Zuanic noted, TILT Holdings has a processing license, but no cultivation or retail operations in the state.

As with other states, location will likely be a major factor in terms of success, the report pointed out several times. Existing license holders could benefit from having a head start.

However, Zuanic wrote, “it is unclear at this stage if incumbents will be able to choose locations for their next stores or if a lottery system will apply.” Such allocation mattered in Michigan and would likely be a critical issue in Ohio as well.

Of the 12 MSOs already operating cannabis stores in the state, four far surpass the others with regard to their potential for value creation. These include:

Vext (potential of a 471% increase in company value) – Vext holds four retails licenses in Ohio, and the company also has an operating cultivation facility with an initial 25,000 square feet fully built out. The first harvest from the facility was achieved in the first quarter of 2023. Vext anticipates the opportunity to operate seven dispensaries in the state when all is said and done. The company currently has a market cap of $45 million, which means it has room to grow. (It should be noted that Vext hired Zuanic to increase its profile).
Acreage (275%) – Acreage has a total of seven licenses in the state: five dispensaries, one cultivator, and one manufacturer. The company had planned to sell these assets, but changed its mind. Like Vext, Acreage also has a market in the low $40 million range.
The Cannabist (185%) – The Cannabist has five active dispensary licenses plus one cultivator and two manufacturer licenses. It has a much higher market cap than the previous two MSOs, coming in at $107 million. The company also lists Ohio as being one of its top five markets.
Ascend (62%) – Ascend has five medical retail licenses, including the pending acquisition of Ohio Patient Access, and one cultivation/processing license. The company said it expects to open more stores. Ascend has a $219 million market cap.

While Zuanic’s report only briefly mentioned the other state leaders – Green Thumb, Verano, and Cresco Labs, each with five stores in operation – he did note that Cresco and Green Thumb typically outperform in the wholesale market in other states.

He also projected that Green Thumb and Cresco Labs would likely grow to eight stores each.

Source link

Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

4Front Ventures

Cannabis executives bring in big bucks in 2023, despite big company losses

Published

3 months ago

February 25, 2025

mscannabiz.com

Leading a cannabis company in the U.S. can apparently be a lucrative career option – at least for executives of many of the largest cannabis operators.

John Hartmann, chief executive officer of Ascend Wellness Holdings (CSE: AAWH-U.CN) (OTCQX: AAWH), was the highest-paid CEO among leading publicly traded cannabis company executives in 2023, according to a review of securities filings by Green Market Report.

Hartmann, who served as Ascend’s CEO from May 2023 until September 2024, received a compensation package worth a total of $3.9 million in 2023, the most recent year for which much cannabis CEO pay data is available.

Hartmann’s multimillion-dollar pay package isn’t too far out of the average for chief executives running large public marijuana companies, according to GMR’s review.

Rather, out of 21 leading public cannabis companies, there were four other CEOs that also made well over $3 million that year. Another 10 CEOs had salaries that topped $1 million. In addition, several of the companies had more than one CEO in 2023.

But the crown for the highest-paid executive is a moving honor. If the analysis is expanded to include 2022, then Jushi Holdings CEO Jim Cacioppo is perhaps the highest-paid chief executive, with $12 million in total compensation over just two years.

If the analysis goes back one additional year, with a range of 2021-2023, then Trulieve Cannabis Corp. CEO Kim Rivers and Verano Holdings CEO George Archos are likely the real winners, with $15.2 million and $19.3 million, respectively, in overall compensation.

The lowest-paid cannabis CEO in 2023 was Peter Caldini at Acreage Holdings, who departed the company in July that year and was paid only a base salary of $254,429. Caldini was succeeded by Dennis Curran, who in 2023 received a total compensation package worth $1.5 million.

For comparison, most U.S. CEOs in mainstream industries earn between $667,525 and $1.1 million, as of Feb. 1, according to Salary.com.

All told, the 21 cannabis companies examined by Green Market Report paid 29 chief executives and executive chairmen a total of $39.3 million in 2023. That includes $13.8 million in base salaries and much more in stock options, incentive compensation, and other financial perks, according to each of the companies’ proxy statements filed last year. Some of those proxy statements included information about executive compensation for 2024, or included prior year compensation figures, but many did not.

Also in 2023, many of those same companies lost a cumulative $2 billion, according to an analysis last year of 20 top public cannabis company earnings. Only Green Thumb Industries (CSE: GTII) (OTCQX: GTBIF) posted a profit that year; the others all lost tens of millions of dollars.

The breakdown

In reviewing compensation packages for high-profile public cannabis company leadership, here’s what Green Market Report found:

4Front Ventures Corp. (CSE: FFNT) (OTCQB: FFNTF)

In 2023, CEO Leonid Gontmakher made a base salary of $400,000, as well as option-based awards of another $400,000, for total compensation worth $800,000.

Gontmakher stepped aside in January 2024, and the 4Front board appointed then-interim Chief Financial Officer Andrew Thut as the company’s new CEO moving forward. 4Front has yet to publish information about Thut’s employment agreement or pay scale.

In 2023 as interim CFO, Thut was paid a base salary of $350,552, a bonus of $297,683, share-based awards of $300,000, and option-based awards of $986,784, for a total compensation package of $1.9 million.

Acreage Holdings (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF)

In 2023, CEO Peter Caldini made a base salary of $254,429. He resigned that July.

Following Caldini, CEO Dennis Curran received a base salary of $358,764 in 2023, stock awards of $797,210, and incentive plan compensation worth $358,750, for a total package worth $1.5 million.

As of January 2024, Curran’s base salary was increased to $420,000, and he’s eligible for a bonus of up to 100% of his salary and a second performance-based bonus of up to 200% of his salary.

Ascend Wellness Holdings (CSE: AAWH-U.CN) (OTCQX: AAWH)

In 2023, interim CEO Daniel Neville received a base salary of $451,923, stock awards of $707,777, and option awards of $116,612, for a total package worth $1.2 million. Neville resigned from the company in November 2023.

When Hartmann took over as permanent CEO, he received a base salary of $566,346, plus stock awards worth $3.4 million, for total compensation worth $3.9 million.

Hartmann stepped down as CEO last year and was replaced by board member Samuel Brill. Brill’s employment agreement delivered him a base salary of $550,000, an annual performance-based bonus and stock awards of 5 million shares.

Ayr Wellness (CSE: AYR.A) (OTCQX: AYRWF)

In 2023, CEO David Goubert’s base salary was $750,004. He received no other compensation.

The year before that, however, Goubert made even less, with a base salary of $112,501 plus a $200,000 bonus, for a total package worth $312,501.

By contrast, Ayr Executive Chairman Jonathan Sandelman was paid a base salary of $1.2 million in both 2022 and 2023. Sandelman made even more in 2021, with a base salary of $586,458 and a $1.2 million bonus, for total compensation worth $1.7 million.

Goubert stepped down from the CEO job in September last year, and the board appointed Steven Cohen, previously an outside legal advisor, as interim CEO. Cohen’s employment agreement has not yet been made public.

Cresco Labs (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ)

In 2023, CEO and founder Charlie Bachtell received only his base salary of $450,000.

The year before that, however, Bachtell received his base salary plus a bonus of $549,000, for total compensation of $999,850.

Curaleaf Holdings (TSX: CURA) (OTCQX: CURLF)

In 2023, CEO Matt Darin received a base salary of $750,000 plus a $431,005 bonus, for total compensation worth $1.1 million.

That same year, Executive Chairman Boris Jordan also made a base salary of $750,000 and received a bonus of $441,340 for a compensation package worth $1.1 million.

Darin stepped down as CEO last year, and Jordan was anointed CEO by the Curaleaf board. It’s not clear yet if his employment agreement or compensation package has changed since then.

Glass House Brands (GLAS.A.U:CA) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF)

In 2023, CEO and Chairman Kyle Kazan received a base salary of $360,000, share-based awards of $966,600, and incentive compensation worth $180,000, for a total package worth $1.5 million.

The year before, however, Kazan made only his base salary of $360,000.

In 2021, Kazan was paid a base salary of $201,753 and made just over $5 million in share-based awards, for total compensation of $5.2 million.

Gold Flora Corp. (Cboe Canada: GRAM) (OTCQB: GRAM)

In 2023, CEO Laurie Holcomb made a base salary of $305,654, stock awards of $288,000 and incentive plan compensation of $12,000, for a total package worth $605,654.

The year before, Holcomb’s base salary was just $180,000, and she got $12,000 in incentive compensation, for total pay package of $192,000.

In July 2023, however, Holcomb’s employment agreement was revised by the board and her base salary was increased to $450,000, and she’s eligible for a performance-based bonus of up to 50% of her salary.

Vireo Growth (CSE: VREO) (OTCQX: VREOF), formerly Goodness Growth Holdings

In 2023, CEO Kyle Kingsley – who stepped down from the job in February that year – was paid a base salary of $275,000, plus $682,256 in option awards, for total compensation of $957,432.

The prior year, Kingsley made even more, with a base salary of $360,000, option awards of $558,435, and stock awards of $672,430, for total compensation of $1.5 million.

Following Kingsley’s resignation, Joshua Rosen was appointed interim CEO and received a base salary of $300,000. Rosen’s total compensation that year was $300,176.

Rosen was made permanent CEO in May 2024, but resigned after just five months, at which point the Vireo board appointed Amber Shimpa the new CEO.

Shimpa’s employment agreement calls for a base salary of $325,000, and she was given 1 million stock units and is eligible for a performance-based cash bonus.

Green Thumb Industries (CSE: GTII) (OTCQX: GTBIF)

In 2023, CEO and founder Ben Kovler received a base salary of $345,013, plus $169,993 in stock awards, $679,997 in option awards and $627,719 in incentive plan compensation, for a total package of $1.8 million.

Kovler earned similar amounts in 2022 with a total package worth $1.8 million and in 2021 with a package worth $1.7 million.

iAnthus Capital Holdings (CSE: IAN) (OTCQB: ITHUF)

In 2023, iAnthus CEO Robert Galvin received a base salary of $414,774, a bonus of $225,000, stock awards worth $350,000, and other compensation of $64,826, for a total package worth just over $1 million.

That was far less than what he earned in 2022, when Galvin’s base salary was $675,000, with $3.4 million in stock awards plus $167,181 in option awards, for a total compensation package worth $4.3 million. The year before that, Galvin made the same $675,000 base salary and also got a bonus of $250,000, for total package worth $925,000.

Galvin stepped down in July 2023 and was succeeded by Richard Proud.

Proud was given a base salary of $219,231, a bonus of $337,500 and stock awards of $3,310,138, for total compensation of $3.5 million in 2023.

Jushi Holdings (CSE: JUSH) (OTCQX: JUSHF)

In 2023, CEO Jim Cacioppo received a base salary of $850,032, a bonus of $1.5 million and option awards of $1.1 million, plus other compensation of $20,677, for total compensation package of $3.5 million.

The year before, in 2022, Cacioppo did even better with a base salary of $750,027, a bonus of $1 million, option awards of $6.7 million and other compensation of $34,031, for a total package worth $8.5 million.

The $12 million in compensation in two years easily makes Cacioppo one of the highest-paid cannabis chief executives in recent times.

MariMed (CSE: MRMD) (OTCQX: MRMD)

In 2023, CEO Jon Levine received a base salary of $375,000, option awards of $315,028, stock awards worth $146,250 and a bonus of $43,194, for a total package worth $879,472.

In December that year, Levine also received 10 million stock shares, and his employment agreement makes him eligible for a bonus of up to 120% of his salary.

Medicine Man Technologies/Schwazze (OTC: SHWZ) (Cboe CA: SHWZ)

In 2023, CEO Justin Dye received a base salary of $148,077, plus stock awards of $178,333, for total compensation of $326,399.

Dye stepped down in May 2023 and was replaced by Nirup Krishnamurthy.

That year, Krishnamurthy was given a base salary of $413,269, a bonus of $100,000, stock awards of $1.8 million, option awards of $813,749 and other compensation of $8,244, for a total package worth $3.2 million.

Krishnamurthy left the CEO position in February last year, and the Schwazze board tapped Forrest Hoffmaster to take over as chief executive. His CEO employment agreement calls for a base salary of $400,000 plus a performance-based bonus of up to $240,000.

Planet 13 Holdings (CSE: PLTH) (OTCQX: PLNH)

In 2023, co-CEOs Robert Groesbeck and Larry Scheffler had the same base salary of $500,000. Groesbeck received $68,429 in other compensation for a total package of $568,429, while Scheffler received $57,407 in other compensation, for a total package worth $557,407.

Both made a decent bit more in 2022, when they received an extra $254,000 in incentive plan compensation on top of their $500,000 base salaries.

Groesbeck and Scheffler’s employment agreements expire at the end of this year.

StateHouse Holdings (CSE: STHZ) (OTCQB: STHZF)

In 2023, CEO Ed Schmults was paid a base salary of $459,440, plus other compensation of $8,330, for a total package of $467,770.

In 2022, Schmults had a base salary of $377,658 and other compensation of $8,923 for a total package worth $386,581.

Last year, StateHouse went belly up and was sent to the auction block for sale just last month.

TerrAscend Corp. (TSND: CA) (OTCQX: TSNDF)

In 2023, CEO Ziad Ghanem had a base salary of $479,808, stock awards of $206,510, incentive plan compensation of $386,798, plus other compensation of $24,555, for a total package worth just over $1 million.

The year before that, Ghanem did significantly better, with a base salary of $412,468, stock awards of $166,500, incentive plan compensation of $170,000, and option awards worth $1.8 million, for a total package worth $2.6 million.

In April last year, the TerrAscend board approved a raise for Ghanem, to a base salary of $527,500.

Tilt Holdings (Cboe CA: TILT) (OTCQB: TLLTF)

In 2023, CEO Tim Conder received a base salary of $235,577, a bonus worth $25,500, stock awards of $118,440 and incentive plan compensation of $133,333, for a total package worth $512,850.

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF)

In 2023, CEO Kim Rivers received a base salary of $750,000, a bonus of $11,638, stock awards worth $780,252, option awards worth $870,308, incentive plan compensation of $941,250 and other compensation of $3,765, for a total package worth $3.3 million.

That likely makes Rivers the highest-paid woman CEO of a public cannabis company, if not the highest-paid female executive in the entire U.S. marijuana industry.

In the two years preceding, however, Rivers made even more. Her salary in 2022 was $500,000, but her total compensation package was $3.9 million, and in 2021, her total compensation package was just over $8 million.

That means Rivers has been paid $15.2 million in just three years.

The Cannabist Co. Holdings (CBST:CA) (OTCQX: CBSTF) (FSE: 3LP)

In 2023, CEO Nicholas Vita received a base salary of $500,000, plus other compensation of $20,000, for a total package worth $520,000.

Vita stepped down as CEO in January last year and was succeeded by David Hart. So far the company has not disclosed Hart’s employment agreement or compensation scale.

Verano Holdings Corp. (VRNO:CA) (OTCQX: VRNOF)

In 2023, CEO George Archos received a base salary of $475,000, a bonus of $301,790, incentive plan compensation of just over $1 million and other compensation of $11,578, for a total package worth $1.8 million.

The year prior, Archos made the same base salary but more in stock awards, for total compensation of just over $2 million. In 2021, however, Archos really cashed in, with a base salary of $375,000, a $200,000 bonus, stock awards worth $14.8 million, and stock options worth $123,537, for a total package worth $15.5 million.

That brings Archos’s three-year compensation to $19.3 million.

Source link

Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Acreage Holdings

The Daily Hit: November 25, 2024

Published

7 months ago

November 25, 2024

mscannabiz.com

The Daily Hit is a recap of the top financial news stories for Monday, November 25, 2024.

On the Site

Creditor asks California court to appoint receiver for Gold Flora, citing ‘dire liquidity issues’

The request stems from debts purchased from the now-defunct cannabis distributor Herbl.

Read more here.

Minnesota judge delays cannabis license lottery after four lawsuits filed against state

It’s not clear when the lottery may now be held, or when cannabis licensing may restart.

Read more here.

Acreage says fixed shares worth zero in Canopy USA deal

The company would need to see Canopy’s stock rise above $5 for fixed shareholders to receive any value.

Read more here.

Cake Brands the latest target for a hemp class action lawsuit

California-based Cake reported $44 million in sales over a nine-month period in 2021.

Read more here.

Illicit cannabis, imported CBD targeted by new rules from Michigan state regulators

Michigan regulators proposed 96 changes to the current legal cannabis framework.

Read more here.

Cannara revenue surges 43%, nets profit in fiscal 2024

Sales were driven by Quebec market share gains as the Canadian cannabis producer continues to expand its canopy.

Read more here.

In Other News

Cannabis advertising

A federal appeals court has upheld Mississippi’s ban on medical marijuana advertising on Friday, rejecting arguments it violates the First Amendment.

Read more here.

Kentucky

Kentucky’s Office of Medical Cannabis and Gov. Andy Beshear announced the first group of 36 dispensary business license winners for most commonwealth counties in a lottery drawing Monday afternoon.

Read more here.

Source link

Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Acreage Holdings

Canopy Growth finalizes Wana Brands acquisition after three years

Published

8 months ago

October 9, 2024

mscannabiz.com

The deal includes Wana Wellness LLC, The CIMA Group LLC and Mountain High Products LLC.

Ontario-based Canopy Growth Corp. (TSX: WEED) (Nasdaq: CGC) announced Wednesday that it has, at long last, completed the acquisition of U.S. marijuana edibles company Wana Brands, nearly a full three years after the $279 million deal was first announced.

“Canopy USA now owns 100% of the outstanding equity interests in Wana,” the company said in a press release, indicating its full intent to expand into the U.S. cannabis market. “Canopy USA is fulfilling its ambition of establishing a leading brand-focused cannabis company in the U.S.”

Canopy USA, a subsidiary of Canopy built specifically to ease the company’s U.S. entrance from Canada, now fully owns Wana Wellness LLC, The CIMA Group LLC and Mountain High Products LLC, which collectively comprise Wana Brands.

Canopy USA has also been on an acquisition spree for months, snapping up two other big-name companies, including California-based Jetty – of which Canopy USA owns 75% – and New York-based multistate operator Acreage Holdings Inc. (CSE:ACRG.A.U) (OTCQX:ACRHF) – a deal that is not expected to close until next year – all to position itself for a splashy entrance into U.S. marijuana.

“With Wana now part of Canopy USA alongside Jetty, Canopy USA is gaining momentum while reinforcing its commitment to building a diverse portfolio of industry-leading brands in the U.S. cannabis market,” Canopy CEO David Klein said in the release this week.

In addition, Wana Brands has expanded into the intoxicating hemp sector with its hemp-based edibles line Wanderous, Wana CEO Joe Hodas said. That should give Canopy USA even more flexibility in the national cannabis market.

Still, Canopy has continued to struggle financially, and reported a net loss of C$127 million in the second quarter of 2024, after losing C$129 million in the first quarter.

Leadership at both Canopy and Wana has also been shifting. Wana founder Nancy Whiteman announced her departure earlier this year, and Klein intends to step down from the helm of Canopy by March.

Source link